Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23

ConclusionThe novel FGF23 assay tested in this study is useful for the differential diagnosis of hypophosphatemic rickets/osteomalacia in a clinical setting.
Source: Journal of Bone and Mineral Metabolism - Category: Orthopaedics Source Type: research